How Your Work History May Affect Your Brain Health - Fisher Center for Alzheimer's Research Foundation
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Your employment history may impact the health of your brain. A new study found that steady employment in midlife was associated with better memory and thinking skills later in life. Having an unstable job history, retiring early or dropping out of the labor force entirely, on the other hand, was linked to poorer cognitive outcomes, with different work patterns affecting men and women differently.
The findings, from researchers at Columbia University Mailman School of Public Health, add to growing evidence that our work histories may affect our brain health. In earlier studies, continuing participation in the labor force has been consistently linked to better cognitive health as we age, whereas not having a job or retiring have been tied to accelerated declines in memory and thinking skills.
This article is an excerpt. To read the full content, visit the original source. Fisher Center for Alzheimer's Research Foundation
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!